Business Standard

Thursday, December 19, 2024 | 07:31 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sun Pharma aims for market share in all verticals amid Covid-19 situation

The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others

Sun Pharma
Premium

The Mumbai-based company also looks to focus on cash preservation and finding a way to reduce the overall debt for the company

Press Trust of India New Delhi
Drug major Sun Pharma aims to gain market share in all the verticals it is present in amid challenges posed by the coronavirus pandemic, as per a top company official.

"Our endeavour will be to gain market share in each of our business by doing better. Despite the near-term uncertainties related to Covid-19, we hope to be able to do better consistently," Sun Pharmaceutical Industries MD Dilip Shanghvi said in an analyst call.

The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others.

Shanghvi said that the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in